References
- McKenna RW, Asplund SL, Kroft SH. Immunopheno-typic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry. Leuk Lymphoma. 2004;45:277–285.
- McKenna RW, Washington LT, Aquino DB, et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood. 2001;98:2498–2507.
- Muehleck SD, McKenna RW, Gale PF, et al. Terminal deoxynucleotidyl transferase (TdT)-positive cells in bone marrow in the absence of hematologic malignancy. Am J Clin Pathol. 1983;79:277–284.
- Davis RE, Longacre TA, Cornbleet PJ. Hematogones in the bone marrow of adults. Immunophenotypic features, clinical settings, and differential diagnosis. Am J Clin Pathol. 1994;102:202–211.
- Longacre TA, Foucar K, Crago S, et al. Hematogones: a multiparameter analysis of bone marrow precursor cells. Blood. 1989;73:543–552.
- Richard G, Brody J, Sun T. A case of acute megakaryocytic leukemia with hematogones. Leukemia. 1993;7:1900–1903.
- Caldwell CW, Poje E, Helikson MA. B-cell precursors in normal pediatric bone marrow. Am J Clin Pathol. 1991;95:816–823.
- Vandersteenhoven AM, Williams JE, Borowitz MJ. Marrow B-cell precursors are increased in lymphomas or systemic diseases associated with B-cell dysfunction. Am J Clin Pathol. 1993;100:60–66.
- Anton-Harisi M, Douna V, Baka M, et al. Acute megakaryoblastic leukemia with increased hematogones in children. J Pediatr Hematol Oncol. 2012;34:e337–e340.
- Fukushima T, Sumazaki R, Koike K, et al. Multicolor flow-cytometric, morphologic, and clonogenic analysis of marrow CD10-positive cells in children with leukemia in remission or nonmalignant diseases. J Pediatr Hematol Oncol. 1998;20:222–228.
- Leitenberg D, Rappeport JM, Smith BR. B-cell precursor bone marrow reconstitution after bone marrow transplantation. Am J Clin Pathol. 1994;102:231–236.
- Bengtsson M, Smedmyr B, Festin R, et al. B lymphocyte regeneration in marrow and blood after autologous bone marrow transplantation: increased numbers of B cells carrying activation and progression markers. Leuk Res. 1989;13:791–797.
- Smedmyr B, Bengtsson M, Jakobsson A, et al. Regeneration of CALLA (CD10+), TdT + and double-positive cells in the bone marrow and blood after autologous bone marrow transplantation. Eur J Haematol. 1991;46:146–151.
- Paolucci P, Hayward AR, Rapson NT. Pre-B and B cells in children on leukaemia remission maintenance treatment. Clin Exp Immunol. 1979;37:259–266.
- Doki N, Haraguchi K, Hagino T, et al. Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2015;94:2055–2060.
- van Wering ER, van der Linden-Schrever BE, Szczepanski T, et al. Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease. Br J Haematol. 2000;110:139–146.
- Christopeit M, Heiland A, Binder M, et al. Impact of physiological BM CD10 + CD19+ B-cell precursors (haematogones) in the post-transplant period in patients with AML. Bone Marrow Transplant. 2013;48:1257–1259.
- Honebrink T, Dayton V, Burke MJ, et al. Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia. Biol Blood Marrow Transplant. 2012;18:930–936.
- Shima T, Miyamoto T, Kikushige Y, et al. Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation. Blood. 2013;121:840–848.
- Montesinos P, Gascon A, Martinez-Cuadron D, et al. Significance of increased blastic-appearing cells in bone marrow following myeloablative unrelated cord blood transplantation in adult patients. Biol Blood Marrow Transplant. 2012;18:388–395.
- Ishii H, Konuma T, Kato S, et al. Impact of hematogones on the long-term outcomes of single-unit cord blood transplantation for adult patients. Leuk Lymphoma. 2017;58:118–126.